<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38216552</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>07</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1520-4995</ISSN><JournalIssue CitedMedium="Internet"><Volume>63</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Feb</Month><Day>06</Day></PubDate></JournalIssue><Title>Biochemistry</Title><ISOAbbreviation>Biochemistry</ISOAbbreviation></Journal><ArticleTitle>Differences in Oligomerization of the SARS-CoV-2 Envelope Protein, Poliovirus VP4, and HIV Vpu.</ArticleTitle><Pagination><StartPage>241</StartPage><EndPage>250</EndPage><MedlinePgn>241-250</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1021/acs.biochem.3c00437</ELocationID><Abstract><AbstractText>Viroporins constitute a class of viral membrane proteins with diverse roles in the viral life cycle. They can self-assemble and form pores within the bilayer that transport substrates, such as ions and genetic material, that are critical to the viral infection cycle. However, there is little known about the oligomeric state of most viroporins. Here, we use native mass spectrometry in detergent micelles to uncover the patterns of oligomerization of the full-length SARS-CoV-2 envelope (E) protein, poliovirus VP4, and HIV Vpu. Our data suggest that the E protein is a specific dimer, VP4 is exclusively monomeric, and Vpu assembles into a polydisperse mixture of oligomers under these conditions. Overall, these results revealed the diversity in the oligomerization of viroporins, which has implications for the mechanisms of their biological functions as well as their potential as therapeutic targets.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Townsend</LastName><ForeName>Julia A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Chemistry and Biochemistry, University of Arizona, Tucson, Arizona 85721, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fapohunda</LastName><ForeName>Oluwaseun</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0001-6545-3471</Identifier><AffiliationInfo><Affiliation>Department of Chemistry and Biochemistry, University of Arizona, Tucson, Arizona 85721, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zhihan</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Chemistry and Biochemistry, University of Arizona, Tucson, Arizona 85721, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pham</LastName><ForeName>Hieu</ForeName><Initials>H</Initials><Identifier Source="ORCID">0009-0000-5542-6357</Identifier><AffiliationInfo><Affiliation>Department of Chemistry and Biochemistry, University of Arizona, Tucson, Arizona 85721, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taylor</LastName><ForeName>Michael T</ForeName><Initials>MT</Initials><Identifier Source="ORCID">0000-0002-7655-7222</Identifier><AffiliationInfo><Affiliation>Department of Chemistry and Biochemistry, University of Arizona, Tucson, Arizona 85721, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kloss</LastName><ForeName>Brian</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>New York Consortium on Membrane Protein Structure, New York Structural Biology Center, New York, New York 10027, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Sang Ho</ForeName><Initials>SH</Initials><Identifier Source="ORCID">0000-0003-2973-7156</Identifier><AffiliationInfo><Affiliation>Department of Chemistry and Biochemistry, University of California, San Diego, La Jolla, California 92093, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Opella</LastName><ForeName>Stanley</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Chemistry and Biochemistry, University of California, San Diego, La Jolla, California 92093, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aspinwall</LastName><ForeName>Craig A</ForeName><Initials>CA</Initials><Identifier Source="ORCID">0000-0002-4359-5812</Identifier><AffiliationInfo><Affiliation>Department of Chemistry and Biochemistry, University of Arizona, Tucson, Arizona 85721, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bio5 Institute, The University of Arizona, Tucson, Arizona 85721, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marty</LastName><ForeName>Michael T</ForeName><Initials>MT</Initials><Identifier Source="ORCID">0000-0001-8115-1772</Identifier><AffiliationInfo><Affiliation>Department of Chemistry and Biochemistry, University of Arizona, Tucson, Arizona 85721, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bio5 Institute, The University of Arizona, Tucson, Arizona 85721, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R35 GM128624</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P41 GM116799</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM008804</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 GM122501</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 GM143120</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Biochemistry</MedlineTA><NlmUniqueID>0370623</NlmUniqueID><ISSNLinking>0006-2960</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086082">Viroporin Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054334">Viral Regulatory and Accessory Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054298">Human Immunodeficiency Virus Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>bioRxiv. 2023 Aug 20:2023.08.18.553902. doi: 10.1101/2023.08.18.553902</RefSource><PMID Version="1">37645758</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="Y">Poliovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086082" MajorTopicYN="N">Viroporin Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054334" MajorTopicYN="N">Viral Regulatory and Accessory Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="Y">HIV Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054298" MajorTopicYN="N">Human Immunodeficiency Virus Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing financial interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>13</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>12</Day><Hour>23</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38216552</ArticleId><ArticleId IdType="mid">NIHMS1959254</ArticleId><ArticleId IdType="pmc">PMC10872257</ArticleId><ArticleId IdType="doi">10.1021/acs.biochem.3c00437</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nieva JL; Madan V; Carrasco L Viroporins: structure and biological functions. Nat Rev Microbiol 2012, 10, 563–574.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7097105</ArticleId><ArticleId IdType="pubmed">22751485</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamb RA; Pinto LH Do Vpu and Vpr of human immunodeficiency virus type 1 and NB of influenza B virus have ion channel activities in the viral life cycles? Virology 1997, 229, 1–11.</Citation><ArticleIdList><ArticleId IdType="pubmed">9123850</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyser JM: Viroporins; Electrophysiology of Unconventional Channels and Pores. 2015. Jul 16;18:153–81. doi: 10.1007/978-3-319-20149-8_7. eCollection 2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-20149-8_7</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez ME; Carrasco L Viroporins. FEBS Lett 2003, 552, 28–34.</Citation><ArticleIdList><ArticleId IdType="pubmed">12972148</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia X; Cheng A; Wang M; Ou X; Sun D; Mao S; Huang J; Yang Q; Wu Y; Chen S; Zhang S; Zhu D; Jia R; Liu M; Zhao XX; Gao Q; Tian B Functions of Viroporins in the Viral Life Cycle and Their Regulation of Host Cell Responses. Front Immunol 2022, 13, 890549.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9202500</ArticleId><ArticleId IdType="pubmed">35720341</ArticleId></ArticleIdList></Reference><Reference><Citation>Giorda KM; Hebert DN Viroporins customize host cells for efficient viral propagation. DNA Cell Biol 2013, 32, 557–564.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3785214</ArticleId><ArticleId IdType="pubmed">23945006</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyser JM; Estes MK Pathophysiological Consequences of Calcium-Conducting Viroporins. Annu Rev Virol 2015, 2, 473–496.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6538290</ArticleId><ArticleId IdType="pubmed">26958925</ArticleId></ArticleIdList></Reference><Reference><Citation>To J; Surya W; Torres J Targeting the Channel Activity of Viroporins. Adv Protein Chem Struct Biol 2016, 104, 307–355.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102763</ArticleId><ArticleId IdType="pubmed">27038378</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiryaev VA; Klimochkin YN Heterocyclic Inhibitors of Viroporins in the Design of Antiviral Compounds. Chem Heterocycl Compd (N Y) 2020, 56, 626–635.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7366462</ArticleId><ArticleId IdType="pubmed">32836315</ArticleId></ArticleIdList></Reference><Reference><Citation>Musharrafieh R; Ma C; Wang J Profiling the in vitro drug-resistance mechanism of influenza A viruses towards the AM2-S31N proton channel blockers. Antiviral Res 2018, 153, 10–22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5891360</ArticleId><ArticleId IdType="pubmed">29518414</ArticleId></ArticleIdList></Reference><Reference><Citation>Watkins LC; DeGrado WF; Voth GA Influenza A M2 Inhibitor Binding Understood through Mechanisms of Excess Proton Stabilization and Channel Dynamics. J Am Chem Soc 2020, 142, 17425–17433.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7564090</ArticleId><ArticleId IdType="pubmed">32933245</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott C; Griffin S Viroporins: structure, function and potential as antiviral targets. J Gen Virol 2015, 96, 2000–2027.</Citation><ArticleIdList><ArticleId IdType="pubmed">26023149</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrei G Vaccines and Antivirals: Grand Challenges and Great Opportunities. Frontiers in Virology 2021, 1.</Citation></Reference><Reference><Citation>Sun Y; Gong L; Yin Y; Zhang L; Sun Q; Feng K; Cui Y; Zhang Q; Zhang X; Deng X; You F; Lu D; Lin Z A Gradient pH-Sensitive Polymer-Based Antiviral Strategy via Viroporin-Induced Membrane Acidification. Adv Mater 2022, 34, e2109580.</Citation><ArticleIdList><ArticleId IdType="pubmed">35229371</ArticleId></ArticleIdList></Reference><Reference><Citation>Luis Nieva J; Carrasco L Viroporins: Structures and Functions beyond Cell Membrane Permeabilization. Viruses 2015, 7, 5169–5171.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4632374</ArticleId><ArticleId IdType="pubmed">26702461</ArticleId></ArticleIdList></Reference><Reference><Citation>Georgieva ER; Borbat PP; Norman HD; Freed JH Mechanism of influenza A M2 transmembrane domain assembly in lipid membranes. Sci Rep 2015, 5, 11757.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4507135</ArticleId><ArticleId IdType="pubmed">26190831</ArticleId></ArticleIdList></Reference><Reference><Citation>Leney AC; Heck AJ Native Mass Spectrometry: What is in the Name? J Am Soc Mass Spectrom 2017, 28, 5–13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5174146</ArticleId><ArticleId IdType="pubmed">27909974</ArticleId></ArticleIdList></Reference><Reference><Citation>Guttman CM; Flynn KM; Wallace WE; Kearsley AJ Quantitative Mass Spectrometry and Polydisperse Materials: Creation of an Absolute Molecular Mass Distribution Polymer Standard. Macromolecules 2009, 42, 1695–1702.</Citation></Reference><Reference><Citation>Tamara S; den Boer MA; Heck AJR High-Resolution Native Mass Spectrometry. Chem Rev 2022, 122, 7269–7326.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9052423</ArticleId><ArticleId IdType="pubmed">34415162</ArticleId></ArticleIdList></Reference><Reference><Citation>Gavriilidou AFM; Sokratous K; Yen HY; De Colibus L High-Throughput Native Mass Spectrometry Screening in Drug Discovery. Front Mol Biosci 2022, 9, 837901.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9047894</ArticleId><ArticleId IdType="pubmed">35495635</ArticleId></ArticleIdList></Reference><Reference><Citation>Barth M; Schmidt C Native mass spectrometry-A valuable tool in structural biology. J Mass Spectrom 2020, 55, e4578.</Citation><ArticleIdList><ArticleId IdType="pubmed">32662584</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend JA; Sanders HM; Rolland AD; Park CK; Horton NC; Prell JS; Wang J; Marty MT Influenza AM2 Channel Oligomerization Is Sensitive to Its Chemical Environment. Anal Chem 2021, 93, 16273–16281.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8665133</ArticleId><ArticleId IdType="pubmed">34813702</ArticleId></ArticleIdList></Reference><Reference><Citation>Verdia-Baguena C; Nieto-Torres JL; Alcaraz A; DeDiego ML; Torres J; Aguilella VM; Enjuanes L Coronavirus E protein forms ion channels with functionally and structurally-involved membrane lipids. Virology 2012, 432, 485–494.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3438407</ArticleId><ArticleId IdType="pubmed">22832120</ArticleId></ArticleIdList></Reference><Reference><Citation>Medeiros-Silva J; Somberg NH; Wang HK; McKay MJ; Mandala VS; Dregni AJ; Hong M pH- and Calcium-Dependent Aromatic Network in the SARS-CoV-2 Envelope Protein. J Am Chem Soc 2022, 144, 6839–6850.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9188436</ArticleId><ArticleId IdType="pubmed">35380805</ArticleId></ArticleIdList></Reference><Reference><Citation>Somberg NH; Wu WW; Medeiros-Silva J; Dregni AJ; Jo H; DeGrado WF; Hong M SARS-CoV-2 Envelope Protein Forms Clustered Pentamers in Lipid Bilayers. Biochemistry 2022, 61, 2280–2294.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9583936</ArticleId><ArticleId IdType="pubmed">36219675</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang R; Qin H; Prasad R; Fu R; Zhou H-X; Cross TA Dimeric Transmembrane Structure of the SARS-CoV-2 E Protein. Communications Biology 2023, 6, 1109.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10620413</ArticleId><ArticleId IdType="pubmed">37914906</ArticleId></ArticleIdList></Reference><Reference><Citation>Karunatilaka KS; Filman DJ; Strauss M; Loparo JJ; Hogle JM Real-Time Imaging of Polioviral RNA Translocation across a Membrane. mBio 2021, 12, e03695–03620.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8545138</ArticleId><ArticleId IdType="pubmed">33622727</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogle JM Poliovirus cell entry: common structural themes in viral cell entry pathways. Annu Rev Microbiol 2002, 56, 677–702.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1500891</ArticleId><ArticleId IdType="pubmed">12142481</ArticleId></ArticleIdList></Reference><Reference><Citation>Panjwani A; Strauss M; Gold S; Wenham H; Jackson T; Chou JJ; Rowlands DJ; Stonehouse NJ; Hogle JM; Tuthill TJ Capsid protein VP4 of human rhinovirus induces membrane permeability by the formation of a size-selective multimeric pore. PLoS Pathog 2014, 10, e1004294.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4125281</ArticleId><ArticleId IdType="pubmed">25102288</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul AV; Schultz A; Pincus SE; Oroszlan S; Wimmer E Capsid protein VP4 of poliovirus is N-myristoylated. Proc Natl Acad Sci U S A 1987, 84, 7827–7831.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC299409</ArticleId><ArticleId IdType="pubmed">2825164</ArticleId></ArticleIdList></Reference><Reference><Citation>Strebel K HIV-1 Vpu - an ion channel in search of a job. Biochim Biophys Acta 2014, 1838, 1074–1081.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3859730</ArticleId><ArticleId IdType="pubmed">23831603</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu JX; Sharpe S; Ghirlando R; Yau WM; Tycko R Oligomerization state and supramolecular structure of the HIV-1 Vpu protein transmembrane segment in phospholipid bilayers. Protein Sci 2010, 19, 1877–1896.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2998723</ArticleId><ArticleId IdType="pubmed">20669237</ArticleId></ArticleIdList></Reference><Reference><Citation>Padhi S; Khan N; Jameel S; Priyakumar UD Molecular dynamics simulations reveal the HIV-1 Vpu transmembrane protein to form stable pentamers. PLoS One 2013, 8, e79779.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3819244</ArticleId><ArticleId IdType="pubmed">24223193</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain A; Das SR; Tanwar C; Jameel S Oligomerization of the human immunodeficiency virus type 1 (HIV-1) Vpu protein--a genetic, biochemical and biophysical analysis. Virol J 2007, 4, 81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2042504</ArticleId><ArticleId IdType="pubmed">17727710</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan N; Geiger JD Role of Viral Protein U (Vpu) in HIV-1 Infection and Pathogenesis. Viruses [Online early access]. DOI: 10.3390/v130814662021.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v130814662021</ArticleId><ArticleId IdType="pmc">PMC8402909</ArticleId><ArticleId IdType="pubmed">34452331</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenberg MR; Weaver LM; Casarotto MG Probing interactions of Vpu from HIV-1 with amiloride-based compounds. Biochim Biophys Acta 2016, 1858, 733–739.</Citation><ArticleIdList><ArticleId IdType="pubmed">26724207</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H; Lin EC; Das BB; Tian Y; Opella SJ Structural determination of virus protein U from HIV-1 by NMR in membrane environments. Biochim Biophys Acta 2015, 1848, 3007–3018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4623708</ArticleId><ArticleId IdType="pubmed">26362058</ArticleId></ArticleIdList></Reference><Reference><Citation>Park SH; Siddiqi H; Castro DV; De Angelis AA; Oom AL; Stoneham CA; Lewinski MK; Clark AE; Croker BA; Carlin AF; Guatelli J; Opella SJ Interactions of SARS-CoV-2 envelope protein with amilorides correlate with antiviral activity. PLoS Pathog 2021, 17, e1009519.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8184013</ArticleId><ArticleId IdType="pubmed">34003853</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu D; Xu R; Dutta K; Cowburn D N-terminal cysteinyl proteins can be prepared using thrombin cleavage. FEBS Lett 2008, 582, 1163–1167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2383316</ArticleId><ArticleId IdType="pubmed">18331839</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiontke A; Oliveira-Birkmeier A; Opitz A; Birkemeyer C Electrospray Ionization Efficiency Is Dependent on Different Molecular Descriptors with Respect to Solvent pH and Instrumental Configuration. PLoS One 2016, 11, e0167502.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5132301</ArticleId><ArticleId IdType="pubmed">27907110</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox JT; Marginean I; Smith RD; Tang K On the ionization and ion transmission efficiencies of different ESI-MS interfaces. J Am Soc Mass Spectrom 2015, 26, 55–62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4276539</ArticleId><ArticleId IdType="pubmed">25267087</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo C; Diao Z; Liu J; Yang B; Zhang J Quantification and evaluation of ion transmission efficiency in two-stage vacuum chamber miniature mass spectrometer. J Mass Spectrom 2022, 57, e4816.</Citation><ArticleIdList><ArticleId IdType="pubmed">35229406</ArticleId></ArticleIdList></Reference><Reference><Citation>McCabe JW; Shirzadeh M; Walker TE; Lin CW; Jones BJ; Wysocki VH; Barondeau DP; Clemmer DE; Laganowsky A; Russell DH Variable-Temperature Electrospray Ionization for Temperature-Dependent Folding/Refolding Reactions of Proteins and Ligand Binding. Anal Chem 2021, 93, 6924–6931.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8119373</ArticleId><ArticleId IdType="pubmed">33904705</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandala VS; McKay MJ; Shcherbakov AA; Dregni AJ; Kolocouris A; Hong M Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers. Nat Struct Mol Biol 2020, 27, 1202–1208.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7718435</ArticleId><ArticleId IdType="pubmed">33177698</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang NJ; Hinner MJ Getting across the cell membrane: an overview for small molecules, peptides, and proteins. Methods Mol Biol 2015, 1266, 29–53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4891184</ArticleId><ArticleId IdType="pubmed">25560066</ArticleId></ArticleIdList></Reference><Reference><Citation>Diamond G; Beckloff N; Weinberg A; Kisich KO The roles of antimicrobial peptides in innate host defense. Curr Pharm Des 2009, 15, 2377–2392.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2750833</ArticleId><ArticleId IdType="pubmed">19601838</ArticleId></ArticleIdList></Reference><Reference><Citation>Moscufo N; Simons J; Chow M Myristoylation is important at multiple stages in poliovirus assembly. J Virol 1991, 65, 2372–2380.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC240589</ArticleId><ArticleId IdType="pubmed">1850017</ArticleId></ArticleIdList></Reference><Reference><Citation>Moscufo N; Chow M Myristate-protein interactions in poliovirus: interactions of VP4 threonine 28 contribute to the structural conformation of assembly intermediates and the stability of assembled virions. J Virol 1992, 66, 6849–6857.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC240287</ArticleId><ArticleId IdType="pubmed">1331497</ArticleId></ArticleIdList></Reference><Reference><Citation>Majeed S; Adetuyi O; Borbat PP; Majharul Islam M; Ishola O; Zhao B; Georgieva ER Insights into the oligomeric structure of the HIV-1 Vpu protein. J Struct Biol 2023, 215, 107943.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10257199</ArticleId><ArticleId IdType="pubmed">36796461</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrero L; Monroy N; Gonzalez ME HIV-1 Vpu protein mediates the transport of potassium in Saccharomyces cerevisiae. Biochemistry 2013, 52, 171–177.</Citation><ArticleIdList><ArticleId IdType="pubmed">23240720</ArticleId></ArticleIdList></Reference><Reference><Citation>Schubert U; Henklein P; Boldyreff B; Wingender E; Strebel K; Porstmann T The human immunodeficiency virus type 1 encoded Vpu protein is phosphorylated by casein kinase-2 (CK-2) at positions Ser52 and Ser56 within a predicted alpha-helix-turn-alpha-helix-motif. J Mol Biol 1994, 236, 16–25.</Citation><ArticleIdList><ArticleId IdType="pubmed">8107101</ArticleId></ArticleIdList></Reference><Reference><Citation>Schubert U; Ferrer-Montiel AV; Oblatt-Montal M; Henklein P; Strebel K; Montal M Identification of an ion channel activity of the Vpu transmembrane domain and its involvement in the regulation of virus release from HIV-1-infected cells. FEBS Lett 1996, 398, 12–18.</Citation><ArticleIdList><ArticleId IdType="pubmed">8946945</ArticleId></ArticleIdList></Reference><Reference><Citation>Park SH; Mrse AA; Nevzorov AA; Mesleh MF; Oblatt-Montal M; Montal M; Opella SJ Three-dimensional structure of the channel-forming trans-membrane domain of virus protein “u” (Vpu) from HIV-1. J Mol Biol 2003, 333, 409–424.</Citation><ArticleIdList><ArticleId IdType="pubmed">14529626</ArticleId></ArticleIdList></Reference><Reference><Citation>Park SH; De Angelis AA; Nevzorov AA; Wu CH; Opella SJ Three-dimensional structure of the transmembrane domain of Vpu from HIV-1 in aligned phospholipid bicelles. Biophys J 2006, 91, 3032–3042.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1578490</ArticleId><ArticleId IdType="pubmed">16861273</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen CP; Lin MH; Chan YT; Chen LC; Ma C; Fischer WB Membrane protein assembly: two cytoplasmic phosphorylated serine sites of Vpu from HIV-1 affect oligomerization. Sci Rep 2016, 6, 28866.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4926278</ArticleId><ArticleId IdType="pubmed">27353136</ArticleId></ArticleIdList></Reference><Reference><Citation>Majeed S; Adetuyi O; Islam MM; Zhao B; Georgieva ER Oligomeric polymorphism of HIV-1 Vpu protein in lipid environment and in solution. bioRxiv 2022, 2022.2008.2026.505453.</Citation></Reference><Reference><Citation>Sharpe S; Yau WM; Tycko R Structure and dynamics of the HIV-1 Vpu transmembrane domain revealed by solid-state NMR with magic-angle spinning. Biochemistry 2006, 45, 918–933.</Citation><ArticleIdList><ArticleId IdType="pubmed">16411768</ArticleId></ArticleIdList></Reference><Reference><Citation>Santa Cruz Garcia AB; Schnur KP; Malik AB; Mo GCH Gasdermin D pores are dynamically regulated by local phosphoinositide circuitry. Nat Commun 2022, 13, 52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8748731</ArticleId><ArticleId IdType="pubmed">35013201</ArticleId></ArticleIdList></Reference><Reference><Citation>Opella SJ Relating structure and function of viral membrane-spanning miniproteins. Curr Opin Virol 2015, 12, 121–125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4476644</ArticleId><ArticleId IdType="pubmed">26057606</ArticleId></ArticleIdList></Reference><Reference><Citation>Cady SD; Hong M Amantadine-induced conformational and dynamical changes of the influenza M2 transmembrane proton channel. Proc Natl Acad Sci U S A 2008, 105, 1483–1488.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2234170</ArticleId><ArticleId IdType="pubmed">18230730</ArticleId></ArticleIdList></Reference><Reference><Citation>Cross TA; Sharma M; Yi M; Zhou HX Influence of solubilizing environments on membrane protein structures. Trends Biochem Sci 2011, 36, 117–125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3161620</ArticleId><ArticleId IdType="pubmed">20724162</ArticleId></ArticleIdList></Reference><Reference><Citation>Cady SD; Schmidt-Rohr K; Wang J; Soto CS; Degrado WF; Hong M Structure of the amantadine binding site of influenza M2 proton channels in lipid bilayers. Nature 2010, 463, 689–692.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2818718</ArticleId><ArticleId IdType="pubmed">20130653</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomaston JL; Konstantinidi A; Liu L; Lambrinidis G; Tan J; Caffrey M; Wang J; Degrado WF; Kolocouris A X-ray Crystal Structures of the Influenza M2 Proton Channel Drug-Resistant V27A Mutant Bound to a Spiro-Adamantyl Amine Inhibitor Reveal the Mechanism of Adamantane Resistance. Biochemistry 2020, 59, 627–634.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7224692</ArticleId><ArticleId IdType="pubmed">31894969</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggen J; Thibaut HJ; Strating J; van Kuppeveld FJM The life cycle of non-polio enteroviruses and how to target it. Nat Rev Microbiol 2018, 16, 368–381.</Citation><ArticleIdList><ArticleId IdType="pubmed">29626210</ArticleId></ArticleIdList></Reference><Reference><Citation>Marc D; Drugeon G; Haenni AL; Girard M; van der Werf S Role of myristoylation of poliovirus capsid protein VP4 as determined by site-directed mutagenesis of its N-terminal sequence. EMBO J 1989, 8, 2661–2668.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC401272</ArticleId><ArticleId IdType="pubmed">2555183</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanczak P; Horst R; Serrano P; Wuthrich K NMR characterization of membrane protein-detergent micelle solutions by use of microcoil equipment. J Am Chem Soc 2009, 131, 18450–18456.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2893019</ArticleId><ArticleId IdType="pubmed">19950959</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoonens M; Catoire LJ; Giusti F; Popot JL NMR study of a membrane protein in detergent-free aqueous solution. Proc Natl Acad Sci U S A 2005, 102, 8893–8898.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1157056</ArticleId><ArticleId IdType="pubmed">15956183</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou HX; Cross TA Influences of membrane mimetic environments on membrane protein structures. Annu Rev Biophys 2013, 42, 361–392.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3731949</ArticleId><ArticleId IdType="pubmed">23451886</ArticleId></ArticleIdList></Reference><Reference><Citation>Orwick-Rydmark M; Arnold T; Linke D The Use of Detergents to Purify Membrane Proteins. Curr Protoc Protein Sci 2016, 84, 4 8 1–4 8 35.</Citation><ArticleIdList><ArticleId IdType="pubmed">27038269</ArticleId></ArticleIdList></Reference><Reference><Citation>Seddon AM; Curnow P; Booth PJ Membrane proteins, lipids and detergents: not just a soap opera. Biochim Biophys Acta 2004, 1666, 105–117.</Citation><ArticleIdList><ArticleId IdType="pubmed">15519311</ArticleId></ArticleIdList></Reference><Reference><Citation>Cady SD; Luo W; Hu F; Hong M Structure and function of the influenza A M2 proton channel. Biochemistry 2009, 48, 7356–7364.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2879269</ArticleId><ArticleId IdType="pubmed">19601584</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaitanya KV: Structure and Organization of Virus Genomes; Genome and Genomics. 2019. Nov 18:1–30. doi: 10.1007/978-981-15-0702-1_1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-981-15-0702-1_1</ArticleId></ArticleIdList></Reference><Reference><Citation>Duffy S Why are RNA virus mutation rates so damn high? PLoS Biol 2018, 16, e3000003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6107253</ArticleId><ArticleId IdType="pubmed">30102691</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayaraman B; Smith AM; Fernandes JD; Frankel AD Oligomeric viral proteins: small in size, large in presence. Crit Rev Biochem Mol Biol 2016, 51, 379–394.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5088105</ArticleId><ArticleId IdType="pubmed">27685368</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue B; Mizianty MJ; Kurgan L; Uversky VN Protein intrinsic disorder as a flexible armor and a weapon of HIV-1. Cell Mol Life Sci 2012, 69, 1211–1259.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11114566</ArticleId><ArticleId IdType="pubmed">22033837</ArticleId></ArticleIdList></Reference><Reference><Citation>D’Orso I; Frankel AD HIV-1 Tat: Its Dependence on Host Factors is Crystal Clear. Viruses 2010, 2, 2226–2234.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3120229</ArticleId><ArticleId IdType="pubmed">21709748</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>